Reference : Mitoxantrone Versus Daunorubicin in Induction-Consolidation Chemotherapy - The Value of ...
Scientific journals : Article
Human health sciences : Hematology
http://hdl.handle.net/2268/13527
Mitoxantrone Versus Daunorubicin in Induction-Consolidation Chemotherapy - The Value of Low-Dose Cytarabine for Maintenance of Remission, and an Assessment of Prognostic Factors in Acute Myeloid Leukemia in the Elderly : Final Report of the Leukemia Cooperative Group of the European Organization for the Research and Treatment of Cancer and th Dutch-Belgian Hemato-Oncology Cooperative Hovon Group Randomized Phase III Study AML-9
English
Löwenberg, B. mailto [ > > ]
Suciu, S. [ > > ]
Archimbaud, E. [ > > ]
Haak, H. [ > > ]
Stryckmans, P. [ > > ]
De Cataldo, R. [ > > ]
Dekker, A. W. [ > > ]
Berneman, Z. N. [ > > ]
Thyss, A. [ > > ]
van der Lelie, J. [ > > ]
Sonneveld, P. [ > > ]
Visani, G. [ > > ]
Fillet, Georges mailto [Université de Liège - ULg > Département des sciences cliniques > Hématologie - Oncologie médicale >]
Hayat, M. [ > > ]
Hagemeijer, A. [ > > ]
Solbu, G. [ > > ]
Zittoun, R. [ > > ]
1998
Journal of Clinical Oncology
American Society of Clinical Oncology
16
872-881
Yes (verified by ORBi)
0732-183X
1527-7755
Alexandria
VA
http://hdl.handle.net/2268/13527

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
127.pdfPublisher postprint784.68 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.